Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with a higher prevalence of antinuclear autoantibodies (ANAs). However, a significant subgroup of patients is ANA negative. It remains to be determined which patient groups carry autoantibodies. METHODS: The association of smoking behaviour, disease status, gender, age and body mass index (BMI) with the presence of autoantibodies in the serum was determined in 124 patients with COPD and 108 non-COPD control subjects. In addition, the role of B cells in autoantibody generation in COPD was investigated by sequencing the antibody repertoire of B cells in the lungs of patients with COPD and of ex-smoking and never-smoking control subjects. RESULTS: Patients with COPD had a significantly higher risk of being serum positive for ANAs (OR 3.12, 95% CI 1.68 to 5.76, p<0.001). ANAs were not significantly associated with age, smoking status, gender or pack-years of smoking. Within the COPD population, subjects with BMI <22 kg/m2 had a significantly higher risk of ANAs (OR 4.93, 95% CI 1.50 to 16.50, p=0.009) than those with normal or high BMI. The antibody repertoire of B cells in the lungs of patients with COPD had a high frequency of positively charged CDR3 residues, a feature which is associated with self-reactive antibodies. CONCLUSION: The results show that COPD is a heterogeneous disease with respect to the prevalence of ANAs. ANAs are primarily associated with the presence of COPD and with low BMI, but not with smoking and forced expiratory volume in 1 s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
New insights into the immunology of chronic obstructive pulmonary disease
Brusselle, G. G., Joos, G. F., & Bracke, K. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60988-4 · Cited by 776
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States
Satoh, M., Chan, E. K. L., Ho, L. A., Rose, K. M., Parks, C. G., Cohn, R. D., Jusko, T. A., Walker, N. J., Germolec, D. R., Whitt, I. Z., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34380 · Cited by 448
Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies
Yadava, K., Pattaroni, C., Sichelstiel, A. K., Trompette, A., Gollwitzer, E. S., Salami, O., von Garnier, C., Nicod, L. P., & Marsland, B. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0779oc · Cited by 184
“While sequence analysis of B cell clones isolated from LFs in COPD lungs has indicated the presence of an oligoclonal, antigen specific humoral response (25), there are conflicting reports regarding the production of self-reactive antibodies (28-32).”
BackgroundAutoantibodies in chronic obstructive pulmonary disease: A systematic review
Byrne, R., Todd, I., Tighe, P. J., & Fairclough, L. C. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.08.007 · Cited by 23
Metadata
- Authors
- Bonarius, H. P. J., Brandsma, C. A., Kerstjens, H. A. M., Koerts, J. A., Kerkhof, M., Nizankowska-Mogilnicka, E., Roozendaal, C., Postma, D. S., & Timens, W.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2010-11-03
- Volume
- 66
- Issue
- 2
- Pages
- 101-107
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2117145322
- Cited by
- 56
- References
- 0
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. https://app.cochat.ai/papers/10.1136/thx.2009.134171
- The paper
- Bonarius, H. P. J., Brandsma, C. A., Kerstjens, H. A. M., Koerts, J. A., Kerkhof, M., Nizankowska-Mogilnicka, E., Roozendaal, C., Postma, D. S., & Timens, W. (2011). Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. Thorax. https://doi.org/10.1136/thx.2009.134171
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.